CClinicalTrials.gg
Active, not recruitingNCT03096743Updated Mar 4, 2026

Evaluating Raised Intracranial Pressure Using MR Elastography

An interventional study of MR elastography and MRI structural brain imaging in Idiopathic Intracranial Hypertension, sponsored by Mayo Clinic. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Investigators will compare magnetic resonance (MR) elastography measurements to other forms of noninvasive methods of detecting raised intracranial pressure, including optical coherence tomography (OCT) imaging measurements of the retinal nerve fiber layer (RNFL) and indirect signs of raised intracranial pressure on magnetic resonance imaging (MRI).

Read the detailed description

The goal of this study is to evaluate the brain elasticity in patients with idiopathic intracranial hypertension (IIH) and other forms of raised intracranial pressure, such as obstructive hydrocephalus. Investigators will evaluate for a correlation between brain stiffness and opening pressure on lumbar puncture. Investigators will also evaluate for changes in brain stiffness after interventions that are aimed at lowering intracranial pressure, including lumbar punctures, medications, and surgical interventions, such as ventriculoperitoneal shunts. Lastly, investigators will compare MR elastography measurements to other forms of noninvasive methods of detecting raised intracranial pressure, including optical coherence tomography (OCT) measurements of the retinal nerve fiber layer (RNFL) and indirect signs of raised intracranial pressure on MRI.

02

Conditions studied

  • Idiopathic Intracranial Hypertension

Browse trials for

03

In context

Pseudotumor Cerebri

52 studies on the registry are indexed under Pseudotumor Cerebri; 21 are open to participants now.

This study's planned enrollment of 200 is above the median of 60 across 36 interventional studies indexed under Pseudotumor Cerebri.

Browse Pseudotumor Cerebri studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

All subjects will have the following inclusion criteria:

  • Group 1: Papilledema from idiopathic intracranial hypertension and other forms of elevated intracranial pressure, including obstructive hydrocephalus
  • Group 2: Patients without raised intracranial pressure.

All subjects will have the following exclusion criteria:

  • Age \<18
  • Pregnancy (self-reported)
  • Individuals for whom MR is contraindicated
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Patients with increased intracranial hypertension

    Patients will receive the MR elastography, MRI structural brain imaging, Optical Coherence Tomography (OCT) imaging, Optic nerve B-scan ultrasound and Lumbar puncture.

    Diagnostic Test: MR elastography · Diagnostic Test: MRI structural brain imaging · Procedure: Lumbar puncture · Diagnostic Test: Optical Coherence Tomography (OCT) imaging · Diagnostic Test: Optic nerve B-scan ultrasound

  • Experimental
    Patient without raised intracranial hypertension

    Patients will receive the MR elastography, MRI structural brain imaging, Optical Coherence Tomography (OCT) imaging, and Optic nerve B-scan ultrasound. Some patients will receive lumbar punctures.

    Diagnostic Test: MR elastography · Diagnostic Test: MRI structural brain imaging · Diagnostic Test: Optical Coherence Tomography (OCT) imaging · Diagnostic Test: Optic nerve B-scan ultrasound

Interventions

  • Diagnostic testMR elastography

    MR elastography image acquisition will be conducted on the Compact 3T MRI scanner using a modified single-shot spin-echo echo-planar imaging pulse sequence.

  • Diagnostic testMRI structural brain imaging

    MRI structural brain imaging will be done on the Compact 3T MRI at the same time as MR elastography.

  • ProcedureLumbar puncture

    All patients with papilledema will get lumbar punctures with opening pressure as part of their work-up for papilledema. A small number of patients without increased intracranial pressure will receive a lumbar puncture.

  • Diagnostic testOptical Coherence Tomography (OCT) imaging

    Optical Coherence Tomography (OCT) imaging will measure the peripapillary retinal nerve fiber layer (RNFL) thickness measurements The images with enhanced depth imaging will be obtained to measure the Bruch's membrane orientation.

  • Diagnostic testOptic nerve B-scan ultrasound

    Ultrasound will be used to measure the optic nerve sheath diameter 3 mm posterior to the posterior scleral surface.

06

What researchers measure

Primary outcomes

  1. MR elastography measurement of the brain elasticity

    The primary outcome measure is the difference in the brain elasticity on MR elastography between patients with raised intracranial pressure and those with normal intracranial pressure

    Time frame: 1-2 weeks prior to lumbar puncture

Secondary outcomes

  1. MRI finding

    The secondary outcome measurement are the retinal nerve fiber layer (RNFL) thickness and Bruch's membrane configuration on the MRI findings of raised intracranial pressure (optic nerve sheath diameter and pituitary/sella ratio). The cutoff from abnormal-to-normal will be established. The sensitivity and specificities will be established and compared against the other secondary outcome measurements and against MR elastography.

    Time frame: 1--2 weeks prior to lumbar puncture

  2. Ocular Coherence Tomography (OCT) finding

    The secondary outcome measurements are the retinal nerve fiber layer (RNFL) thickness and Bruch's membrane configuration using ocular coherence tomography (OCT) of raised intracranial pressure (optic nerve sheath diameter and pituitary/sella ratio). The cutoff from abnormal-to-normal will be established. The sensitivity and specificities will be established and compared against the other secondary outcome measurements and against MR elastography

    Time frame: 1--2 weeks prior to lumbar puncture

  3. Optic Nerve B-scan ultrasound finding

    The secondary outcome measurement are the retinal nerve fiber layer (RNFL) thickness and Bruch's membrane configuration on the optic nerve B-scan ultrasound findings of raised intracranial pressure (optic nerve sheath diameter and pituitary/sella ratio). The cutoff from abnormal-to-normal will be established. The sensitivity and specificities will be established and compared against the other secondary outcome measurements and against MR elastography.

    Time frame: 1--2 weeks prior to lumbar puncture

07

Study locations

1 site
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03096743
Lead sponsor
Mayo Clinic
Collaborators
National Eye Institute (NEI)
Responsible party
John J Chen (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Mar 30, 2017
Start date
Jan 10, 2017
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2031 (estimated)
Last update
Mar 4, 2026

Study contacts

John J Chen, M.D., Ph.D.
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion